AADC Inadequacy To Be Handled By A Novel Gene Therapy
In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been...
New Drug Explored For Epilepsy Gets $3M Funding In Australia
More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the...
Faster Clinical Trial Nods Planned By The UK To Curb Issues
The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research.
In...
Pharma Drugs Gain From Tardigrade Proteins, Says Research
The study of how the microscopic creatures called tardigrades can survive extreme scenarios has led to a significant breakthrough that could go on to...
EMA Keeping A Close Watch On Critical Medicine Shortages
During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA) gave an update on the continued efforts of the...
Pathways Laid Down By The CMS For Drug Price Negotiations
The Centers for Medicare & Medicaid Services issued preliminary instructions on March 15 on how it intends to negotiate medication pricing under Medicare, a...
MHRA In The UK To Assess Stem Cell Robots For Cell Therapies
The Medicines and Healthcare Products Regulatory Agency's (MHRA) UK stem cell bank is trailing a new and innovative robot that would grow stem cells.
The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...